Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR2C1 |
| Upstream (Parents) |
|---|
| (<<) NR5A2 → NR2C1 |
| (<<) ZNF81 → NR2C1 |
| (<<) FLI1 → NR2C1 |
| (<<) MAFB → NR2C1 |
| (<<) ELF3 → NR2C1 |
| (<<) ZEB2 → NR2C1 |
| (<<) E2F1 → NR2C1 |
| (<<) TFEC → NR2C1 |
| (<<) FOXA2 → NR2C1 |
| (<<) HCLS1 → NR2C1 |
| (<<) ETV5 → NR2C1 |
| (<<) STRN3 → NR2C1 |
| Downstream (Children) |
|---|
| NR2C1 → ISL1 (>>) |
| NR2C1 → HOXA2 (>>) |
| NR2C1 → NR2F6 (>>) |
| NR2C1 → POU3F3 (>>) |
| NR2C1 → HNF1B (>>) |
| NR2C1 → PBX1 (>>) |
| NR2C1 → MEF2D (>>) |
| NR2C1 → NR1I2 (>>) |
| NR2C1 → HOXD12 (>>) |
| NR2C1 → CBFA2T2 (>>) |
| NR2C1 → ATF6B (>>) |
| NR2C1 → SATB1 (>>) |
| NR2C1 → ETS2 (>>) |
| NR2C1 → RUNX3 (>>) |
